Harbin Pharmaceutical Group Co Ltd (600664) — Financial Flexibility Index
Harbin Pharmaceutical Group Co Ltd (600664) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of CN¥-159.00 Million (operating CF CN¥-192.19 Million minus capex CN¥33.19 Million) represents 0% of total liabilities (CN¥7.67 Billion). Check 600664 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Harbin Pharmaceutical Group Co Ltd Financial Flexibility Index (1998–2024)
Historical Financial Flexibility Index trend for Harbin Pharmaceutical Group Co Ltd across 27 annual periods. See Harbin Pharmaceutical Group Co Ltd (600664) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Harbin Pharmaceutical Group Co Ltd (1998–2024)
Year-by-year free cash flow to debt coverage for Harbin Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see Harbin Pharmaceutical Group Co Ltd (600664) total market value.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.10x | CN¥893.31 Million | CN¥792.50 Million | CN¥8.53 Billion | ▼ -12.1% |
| 2023 | 0.12x | CN¥1.04 Billion | CN¥949.67 Million | CN¥8.69 Billion | ▲ +42.2% |
| 2022 | 0.08x | CN¥711.74 Million | CN¥622.09 Million | CN¥8.48 Billion | ▲ +923.9% |
| 2021 | -0.01x | CN¥-85.74 Million | CN¥-162.44 Million | CN¥8.42 Billion | ▲ +86.9% |
| 2020 | -0.08x | CN¥-609.94 Million | CN¥-728.15 Million | CN¥7.86 Billion | ▼ -107.0% |
| 2019 | -0.04x | CN¥-245.94 Million | CN¥-284.94 Million | CN¥6.56 Billion | ▼ -126.1% |
| 2018 | 0.14x | CN¥806.84 Million | CN¥692.72 Million | CN¥5.62 Billion | ▲ +255.3% |
| 2017 | 0.04x | CN¥251.23 Million | CN¥149.22 Million | CN¥6.22 Billion | ▼ -90.5% |
| 2016 | 0.43x | CN¥2.89 Billion | CN¥2.78 Billion | CN¥6.75 Billion | ▲ +37.6% |
| 2015 | 0.31x | CN¥1.95 Billion | CN¥1.66 Billion | CN¥6.28 Billion | ▲ +53.5% |
| 2014 | 0.20x | CN¥1.51 Billion | CN¥1.14 Billion | CN¥7.47 Billion | ▲ +203.7% |
| 2013 | 0.07x | CN¥511.54 Million | CN¥141.64 Million | CN¥7.68 Billion | ▼ -44.0% |
| 2012 | 0.12x | CN¥833.61 Million | CN¥557.83 Million | CN¥7.02 Billion | ▲ +208.5% |
| 2011 | 0.04x | CN¥202.06 Million | CN¥-31.56 Million | CN¥5.25 Billion | ▼ -86.2% |
| 2010 | 0.28x | CN¥1.45 Billion | CN¥1.15 Billion | CN¥5.22 Billion | ▼ -46.0% |
| 2009 | 0.52x | CN¥2.07 Billion | CN¥1.85 Billion | CN¥4.02 Billion | ▲ +178.3% |
| 2008 | 0.19x | CN¥721.67 Million | CN¥578.59 Million | CN¥3.89 Billion | ▼ -1.3% |
| 2007 | 0.19x | CN¥825.16 Million | CN¥650.16 Million | CN¥4.40 Billion | ▼ -21.8% |
| 2006 | 0.24x | CN¥1.06 Billion | CN¥738.08 Million | CN¥4.43 Billion | ▼ -15.3% |
| 2005 | 0.28x | CN¥1.20 Billion | CN¥757.76 Million | CN¥4.24 Billion | ▲ +76.0% |
| 2004 | 0.16x | CN¥577.60 Million | CN¥149.01 Million | CN¥3.59 Billion | ▼ -28.5% |
| 2003 | 0.23x | CN¥776.56 Million | CN¥302.83 Million | CN¥3.45 Billion | ▼ -10.6% |
| 2002 | 0.25x | CN¥774.47 Million | CN¥383.44 Million | CN¥3.08 Billion | ▼ -37.2% |
| 2001 | 0.40x | CN¥1.24 Billion | CN¥604.13 Million | CN¥3.09 Billion | ▲ +0.8% |
| 2000 | 0.40x | CN¥1.12 Billion | CN¥541.70 Million | CN¥2.82 Billion | ▲ +90.0% |
| 1999 | 0.21x | CN¥615.64 Million | CN¥431.22 Million | CN¥2.94 Billion | ▲ +52.4% |
| 1998 | 0.14x | CN¥322.14 Million | CN¥221.41 Million | CN¥2.34 Billion | — |